Fig. 4
From: A novel model for predicting immunotherapy response and prognosis in NSCLC patients
Risk categorization for PFS/OS in light of the prediction model. A–H. K–M survival curves for PFS of NSCLC Patients in the high-risk and low-risk groups in the Training Cohort (A, C) and Validation Cohort (B, D) in the RF Model and Nomogram model. K–M survival curves for PFS of NSCLC patients categorized by SIS score (0, 1, 2), LIPI score (0, 1, 2) in the training cohort (E, G) and validation cohort (F, H). L–P. K–M survival curves for OS of NSCLC Patients in the high-risk and low-risk groups in the Training Cohort (I, K) and Validation Cohort (J, L) in the RF Model and Nomogram model. K–M survival curves for OS of NSCLC patients categorized by SIS score (0, 1, 2), LIPI score (0, 1, 2) in the training cohort (M, O) and validation cohort (N, P)